Influence of age on outcome from thrombolysis in acute stroke: A controlled comparison in patients from the virtual international stroke trials archive (VISTA)

Stroke

Volumn 41, Issue 12, 2010, Pages 2840-2848

  Mishra, Nishant Kumar ^a   Diener, Hans Christoph ^b   Lyden, Patrick D ^c   Bluhmki, Erich ^d   Lees, Kennedy R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

elderly; outcome; thrombolysis

Indexed keywords

AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; PLASMINOGEN ACTIVATORS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650417390     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.586206     Document Type: Article

References (45)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
2. Sandercock P. Thrombolysis for acute ischaemic stroke after ECASS3- what are remaining uncertainties? Oral Presentations, BASP Trainee Breakfast Session in UK Stroke Forum, 2009. Available at: www.stroke.org.uk/document.rm?id=2511. Accessed January 10, 2010. Int J Stroke. 2009;4(suppl 2):5.
3. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
4. Derex L, Nighoghossian N. Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat Rev Neurol. 2009;5:506-511.
5. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
6. Actilyse (prepared by the committee for proprietary medicinal products (CPMP) for the European Agency for the Evaluation of Medicinal Products, article 29 of directive 2001/83/EC for Actilyse, dated November 21, 2002; CPMP/3346/02-EN). 2002; Available at: www.ema.europa.eu/ docs/en-GB/document- library/Referrals-document/Actilyse-29/ WC500010327.pdf. Accessed January 10, 2010.
7. Guidelines for stroke management from the European Stroke Organization. Available at: www.eso-stroke.org/pdf/ESO08-Guidelines-Original-english. pdf 2008. Accessed January 10, 2010.
8. Marini C, Baldassarre M, Russo T, De Santis F, Sacco S, Ciancarelli I, Carolei A. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology. 2004;62:77-81.
9. Di Carlo A, Baldereschi M, Gandolfo C, Candelise L, Ghetti A, Maggi S, Scafato E, Carbonin P, Amaducci L, Inzitari D. Stroke in an elderly population: incidence and impact on survival and daily function. The Italian Longitudinal Study on Aging. Cerebrovasc Dis. 2003;16:141-150.
10. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of > or = 80 versus versus <80 years of age- a systematic review across cohort studies. Age Ageing 2006; 35; 572-580
11. Engelter ST, Reichhart M, Sekoranja L, Georgiadis D, Baumann A, Weder B, Muller F, Luthy R, Arnold M, Michel P, Mattle HP, Tettenborn B, Hungerbuhler HJ, Baumgartner RW, Sztajzel R, Bogousslavsky J, Lyrer PA. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology. 2005;65:1795-1798.
12. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, Lees KR. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke. 2010;41:e25-33.
13. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Low-itzsch K, Heidrich J, Hermanek P, Leffmann C, Sitzer M, Biegler M, Buecker-Nott HJ, Berger K. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA. 2004;292:1831-1838.
14. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke. 2006; 37:440-446.
15. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119-2125.
16. Dunnell K. Ageing and mortality in the UK- national statistician's annual article on the population. Popul Trends. 2008;Winter:6-23.
17. Ali M, Bath PM, Curram J, Davis SM, Diener HC, Donnan GA, Fisher M, Gregson BA, Grotta J, Hacke W, Hennerici MG, Hommel M, Kaste M, Marler JR, Sacco RL, Teal P, Wahlgren NG, Warach S, Weir CJ, Lees KR. The Virtual International Stroke Trials Archive. Stroke. 2007;38: 1905-1910.
18. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007; 369:275-282.
19. Points to consider on clinical investigation of medicinal products for the treatment of acute stroke. The European Agency for the Evaluation of Medicinal Products. Committee for proprietary medicinal products (CPMP) at London, Sep 2001, Reference: CPMP/EWP/560/98. Available at: www.tga.gov.au/docs/ pdf/euguide/ewp/056098en.pdf. Accessed January 10, 2010.
20. Lees KR, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Ashwood T, Hardemark HG, Wasiewski W, Emeribe U, Zivin JA. Additional outcomes and subgroup analyses of NXY-059 for acute is-chemic stroke in the SAINT I trial. Stroke. 2006;37:2970-2978.
21. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hardemark HG, Rodichok L. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke. 2008;39:1751-1758.
22. Gray LJ, Bath PM, Collier T. Should stroke trials adjust functional outcome for baseline prognostic factors? Stroke. 2009;40:888-894.
23. Saver JL, Yafeh B. Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials. Stroke. 2007;38:414-416.
24. Weimar C, Konig IR, Kraywinkel K, Ziegler A, Diener HC. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke. 2004;35:158-162.
25. Savitz SI, Benatar M, Saver JL, Fisher M. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis. 2008;26:156-162.
26. Wahlgren N. Systemic thrombolysis in clinical practice: what have we learned after the Safe Implementation of Thrombolysis in Stroke Monitoring Study? Cerebrovasc Dis. 2009;27:168-176.
27. Lees KR, Ford GA, Muir KW, Ahmed N, Dyker AG, Atula S, Kalra L, Warburton EA, Baron JC, Jenkinson DF, Wahlgren NG, Walters MR. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the Safe Implementation of Thrombolysis in Stroke (SITS) register. QJM. 2008;101:863-869.
28. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley Jr. EC, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
29. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, Roine RO, Toni D, Lees KR. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372: 1303-1309.
30. Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4:200-205.
31. Jensen MB, Chacon MR, Sattin JA, Aleu A, Lyden PD. The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack. Neurologist. 2008;14:243-246.
32. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997;28: 2109-2118.
33. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne M-H, Hennerici M; ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasmin-ogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
34. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
35. Ford G, Ahmed N, Wahlgren N; for SITS Collaborators. Thrombolysis for acute ischemic stroke in patients older than 80 years: results from SITS (Safe Implementation of Thrombolysis in Stroke Register). Cerebrovasc Dis. 2006; 21:36.
36. Ringleb PA, Schwark C, Kohrmann M, Kulkens S, Juttler E, Hacke W, Schellinger PD. Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry. 2007;78: 690-693.
37. Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry. 2006; 77:826-829.
38. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thrombolytic Therapy in Acute Ischemic Stroke Study investigators. Stroke. 2000;31:811-816.
39. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282:2019-2026.
40. Toni D, Lorenzano S. Intravenous thrombolysis with rt-PA in acute stroke patients aged > or = 80 years. Int J Stroke. 2009;4:21-22.
41. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P. The Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials. 2008;9:37.
42. Sandercock P, Wardlaw J, Lindley R; for IST-3 Collaborative Group. Age and time to randomisation in the 2017 patients recruited to date in the third International Stroke Trial (IST-3). Cerebrovasc Dis. 2010.29. Available at: www.esc-archive.eu/barcelona10/bar-author-4.asp. Accessed May 25, 2010.
43. Poppe AY, Hill MD. Acute ischaemic stroke in patients aged 80 years and older: focus on the tolerability of thrombolytic agents. Drugs Aging. 2008;25:95-103.
44. Vatankhah B, Dittmar MS, Fehm NP, Erban P, Ickenstein GW, Jakob W, Bogdahn U, Horn M. Thrombolysis for stroke in the elderly. J Thromb Thrombolysis. 2005;20:5-10.
45. Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis. 2008;25:129-135.